Dark Pharma · DP-043
Western Drugs Cost $15,000 A Year. He Offered The Same Treatment For A Dollar A Day.
Cipla, led by Yusuf Hamied, offered an HIV treatment to Médecins Sans Frontières for $350 per year, contrasting sharply with the $10,000-$15,000 cost of Western drugs. This move came at the height of a legal dispute among pharmaceutical companies over generic drug production rights in South Africa, influencing global HIV treatment accessibility for years to come.
Case Assets
The Case Debrief is free to view. Full Case Study, Teaching Notes, Slide Deck, Discussion Guide, and Assessment are available with a Premium subscription.
Brief the Board
PREMIUM
🔒 Unlock
Learn the Case
FREE — included
Study the Case
PREMIUM
🔒 Unlock
Teach the Case
PREMIUM
🔒 Unlock
Present the Case
PREMIUM
🔒 Unlock
Run a Team Discussion
PREMIUM
🔒 Unlock
Test Your Judgement
PREMIUM
🔒 Unlock
Watch the Full Episode
The complete cinematic audio documentary — Dark Pharma
Unlock the Full Case Library
Get every Case Study, Slide Deck, Teaching Notes, Discussion Guide, and Assessment — across a growing library of business cases.
View Pricing →